Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T07:13:53.885Z Has data issue: false hasContentIssue false

Proteolytic Activity During the Growth of C6 Astrocytoma in the Murine Spheroid Implantation Model

Published online by Cambridge University Press:  18 September 2015

Indrasen S. Vaithilingam*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, Victoria Hospital (ISV, WMcD, ECS, RFD), and the Department of Biochemistry (RAC), University of Western Ontario, London
Warren McDonald*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, Victoria Hospital (ISV, WMcD, ECS, RFD), and the Department of Biochemistry (RAC), University of Western Ontario, London
Eric C. Stroude*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, Victoria Hospital (ISV, WMcD, ECS, RFD), and the Department of Biochemistry (RAC), University of Western Ontario, London
Robert A. Cook*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, Victoria Hospital (ISV, WMcD, ECS, RFD), and the Department of Biochemistry (RAC), University of Western Ontario, London
Rolando F. Del Maestro*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, Victoria Hospital (ISV, WMcD, ECS, RFD), and the Department of Biochemistry (RAC), University of Western Ontario, London
*
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

General protease and collagenase IV activity are involved in the remodelling of the vascular basement membrane that occurs during tumor-induced angiogenesis. This study has assessed the level of these enzymes in tumor, peritumoral or contralateral cerebral cortex tissue during the growth of C6 astrocytoma in the rat spheroid implantation model. General proteolytic activity was increased in tumor tissue beginning on day 8 following spheroid implantation, then increased to a maximum value on day 11 and decreased to control values on day 18. A similar pattern was seen for collagenase IV activity but maximal activity occurred on day 13. The peritumor and tumor patterns of activity were similar. General protease activity was increased in the hemisphere contralateral to the tumor suggesting that the growth of C6 astrocytoma in rat brain was influencing biochemical events distant from the tumor. C6 astrocytoma cells orchestrate a cascade of proteolytic events which may play a crucial role in angiogenesis associated with tumor growth in the model system studied.

Type
Articles
Copyright
Copyright © Canadian Neurological Sciences Federation 1992

References

1. Wang, BS, McLoughlin, GA, Richie, JP, et al. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res 1980; 40: 288292.Google ScholarPubMed
2. Sloane, BF, Bunn, JR, Honn, KV.Lysosomal cathepsin B: correlation with metastatic potential. Science 1981; 212: 11511153.CrossRefGoogle ScholarPubMed
3. Turpeenniemi-Hujanen, T, Thorgeirsson, UP, Hart, IR, et al. Expression of collagenase IV (Basement Membrane Collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst 1985; 75: 99103.Google ScholarPubMed
4. Thorgeirsson, UP, Turpeenniemi-Hujanen, T, Williams, JE, et al. N1H-3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 1985; 5: 259262.Google ScholarPubMed
5. Vaithilingam, IS, Stroude, EC, McDonald, W, et al. General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids. J Neuro-oncol 1991; 10: 203212.CrossRefGoogle ScholarPubMed
6. Del Maestro, RF, Lopez-Torres, M, McDonald, W, et al. The effect of tumor necrosis factor-a on human malignant glial cells. J Neurosurg (in press).Google Scholar
7. Gimbrone, MA Jr, Contran, RS, Leapman, SB, et al. Tumor and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 1974; 52: 413428.CrossRefGoogle ScholarPubMed
8. Ausprunk, K, Knighton, DR, Folkman, J.Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Am J Pathol 1975; 79:597618.Google Scholar
9. Weiss, JB, Brown, RA, Kumar, S, et al. An angiogenic factor isolated from tumors: a potent low-molecular weight compound. Br J Cancer 1979; 3:493496.CrossRefGoogle Scholar
10. Folkman, J, Cotran, RS.Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207248.Google ScholarPubMed
11. Folkman, J.How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 1986; 46: 467473.Google Scholar
12. Zetter, BR.Migration of capillary endothelial cells is stimulated by tumor-derived factors. Nature 1980; 285: 4143.CrossRefGoogle Scholar
13. Del Maestro, RF, Megyesi, JF, Farrell, CL.Mechanisms of tumorassociated edema: a review. Can J Neurol Sci 1990; 17: 177183.CrossRefGoogle ScholarPubMed
14. Mignatti, P, Robbins, E, Rifkin, DB.Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986; 47: 487498.CrossRefGoogle ScholarPubMed
15. Mignatti, P, Tsuboi, R, Robbins, E, et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 1989; 108: 671682.CrossRefGoogle ScholarPubMed
16. Bosman, FT, Cluetjens, J, Beek, C, et al. Basement membrane heterogeneity. Histochem J 1989; 21: 629633.CrossRefGoogle ScholarPubMed
17. Farrell, CL, Stewart, PA, Del Maestro, RF.A new glioma model in rat: the C6 astrocytoma spheroid implantation technique, permeability and vascular characterization. J Neuro-oncol 1987; 4: 403415.CrossRefGoogle ScholarPubMed
18. Rice, RH, Means, GE.Radioactive labelling of proteins in vitro. 3 Biol Chem 1971; 246: 831832.CrossRefGoogle ScholarPubMed
19. Mallya, SK, Mookhtiar, KA, van Wart, WE.Accurate quantitative assays for the hydrolysis of soluble type I, II, and III 3H-acety-lated collagens by bacterial and tissue collagenases. Anal Biochem 1985; 158: 334345.CrossRefGoogle Scholar
20. Mookhtiar, KA, Mallya, SK, van Wart, HE.Properties of radiolabelled type I, II, and III collagens related to their use as substrates in collagenase assays. Anal Biochem 1986; 158: 322333.CrossRefGoogle ScholarPubMed
21. Bradford, MM.A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.CrossRefGoogle ScholarPubMed
22. Thompson, WD, Shiach, JK, Fraser, RA, et al. Tumors acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 1987; 151:323332.CrossRefGoogle Scholar
23. Woessner, JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 21452154.CrossRefGoogle Scholar
24. Senior, RM, Griffin, GL, Fliszar, CJ, et al. Human 92- and 72-kilo- dalton type IV collagenases are elastases. J Biol Chem 1991; 266: 78707875.Google Scholar
25. DeClerck, YA, Yean, TD, Ratzkin, BJ.Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 1989; 264: 1744517453.Google Scholar
26. Stetler-Stevenson, WG, Krutzsch, HC, Liotta, LA.Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 1989; 264: 1737417378.CrossRefGoogle ScholarPubMed
27. Stetler-Stevenson, WG.Type IV collagenases in tumor invasion and metastasis. Cancer Metabol Rev 1990; 9: 289303.CrossRefGoogle ScholarPubMed
28. Farrell, CL.The microcirculation in a glioma model. Ph.D. Thesis. University of Western Ontario 1988.Google Scholar
29. Blood, CH, Zetter, BR.Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochem Biophys Acta 1990; 1032:89118.Google ScholarPubMed
30. Paganetti, PA, Caroni, P, Schwab, ME.Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metallo-protease. J Cell Biol 1988; 107: 22812291.CrossRefGoogle Scholar
31. Halaka, AN, Bunning, RAD, Bird, CC.Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J Neurosurg 1983; 59: 461466.CrossRefGoogle ScholarPubMed
32. Khokha, R, Waterhouse, P, Yagel, S, et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 243: 947950.CrossRefGoogle ScholarPubMed
33. Polverini, PJ, Leibovich, SJ.Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984; 51: 635642.Google ScholarPubMed
34. Liotta, LA.Tumor invasion and metastases – Role of the extracellular matrix. Rhoads Memorial Award Lecture. Cancer Res 1986; 46: 17.Google ScholarPubMed
35. Testa, JE, Quigley, JP.Reversal of misfortune: TIMP-2 inhibits tumor cell invasion. J Natl Cancer Inst 1991; 83: 740742.CrossRefGoogle ScholarPubMed